E-LIB Suche - Ergebnisse für: Pfirrmann, Markus

1

How to interpret the EURO-SKI study and its treatment-free ..:

Pfirrmann, Markus ; Saussele, Susanne ; Mahon, François-Xavier.
Leukemia. 38 (2024) 2 - p. 460-462 , 2024

Link: https://doi.org/10.1038/..

2

Analysis of adverse events with modern statistical methods:

Manz, Kirsi , 2023

Link: https://nbn-resolving.de..

3

P1542: RUXOLITINIB IN COVID-19 PATIENTS WITH DEFINED HYPERI..:

Birndt, Sebastian ; Hammersen, Jakob ; Döhner, Konstanze...
HemaSphere. 7 (2023) S3 - p. e2130832 , 2023

Link: https://doi.org/10.1097/..

4

S156: FRONTLINE ASCIMINIB COMBINATION IN CHRONIC PHASE CHRO..:

Ernst, Thomas ; Le Coutre, Philipp ; Crysandt, Martina...
HemaSphere. 7 (2023) S3 - p. e34543a6 , 2023

Link: https://doi.org/10.1097/..

5

S157: NILOTINIB VS. NILOTINIB + PEG-INTERFERON ΑLPHA INDUCT..:

Hochhaus, Andreas ; Burchert, Andreas ; Saußele, Susanne...
HemaSphere. 7 (2023) S3 - p. e4695659 , 2023

Link: https://doi.org/10.1097/..

6

S159: HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH CHRON..:

Efficace, Fabio ; Mahon, Francois-Xavier ; Richter, Johan...
HemaSphere. 7 (2023) S3 - p. e0972454 , 2023

Link: https://doi.org/10.1097/..

7

Step-in dosing of bosutinib in pts with chronic phase chron..:

Isfort, Susanne ; Manz, Kirsi ; Teichmann, Lino L....
Annals of Hematology. 102 (2023) 10 - p. 2741-2752 , 2023

Link: https://doi.org/10.1007/..

8

S155: PROGNOSTIC FACTORS FOR 3-YEAR MAJOR MOLECULAR RESPONS..:

Pfirrmann, Markus ; Mahon, Francois-Xavier ; Dulucq, Stéphanie...
HemaSphere. 7 (2023) S3 - p. e230884b , 2023

Link: https://doi.org/10.1097/..

9

ASXL1 mutations predict inferior molecular response to nilo..:

Schönfeld, Lioba ; Rinke, Jenny ; Hinze, Anna...
Leukemia. 36 (2022) 9 - p. 2242-2249 , 2022

Link: https://doi.org/10.1038/..

10

Decline in the number of patients with meningitis in German..:

Völk, Stefanie ; Pfirrmann, Markus ; Koedel, Uwe...
Journal of Neurology. 269 (2022) 7 - p. 3389-3399 , 2022

Link: https://doi.org/10.1007/..

11

Prognostic Scores for Patients with Chronic Myeloid Leukemi..:

, In: Hematologic Malignancies; Chronic Myeloid Leukemia,

Pfirrmann, Markus ; Lauseker, Michael ; Hoffmann, Verena S.. - p. 119-143 , 2021

Link: https://doi.org/10.1007/..

12

CXCL13 and CXCL9 CSF Levels in Central Nervous System Lymph..:

Masouris, Ilias ; Manz, Kirsi ; Pfirrmann, Markus...
Frontiers in Neurology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

13

Supplementation with Bifidobacterium longum subspecies infa..:

Ziegler, Anette-Gabriele ; Arnolds, Stefanie ; Kölln, Annika...
BMJ Open. 11 (2021) 11 - p. e052449 , 2021

Link: https://doi.org/10.1136/..

14

Oral insulin immunotherapy in children at risk for type 1 d..:

Assfalg, Robin ; Knoop, Jan ; Hoffman, Kristi L....
Diabetologia. 64 (2021) 5 - p. 1079-1092 , 2021

Link: https://doi.org/10.1007/..

15

Prognosefaktoren für Patienten, die in fortgeschrittener P..:

Bachl, Katharina , 2020

Link: https://nbn-resolving.de..